Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Pharm ; 16(3): 987-994, 2019 03 04.
Article in English | MEDLINE | ID: mdl-30624945

ABSTRACT

A combination of different chemotherapy approaches can obtain the best response for many cancers. However, the greatest challenge is the development of a nanoparticle formulation that can encapsulate different chemotherapeutic agents to achieve the proper synergetic chemotherapy for the tumor. Here, amphiphilic ferrocenium-tetradecyl (Fe-C14) was constructed to form cationic micelles in an aqueous solution via self-assembly. Then, it was coated by hyaluronic acid (HA) through electrostatic interactions to generate HA-Fe-C14 micelles. The HA-Fe-C14 micelles were used to deliver doxorubicin (DOX), and it showed that the DOX could be released rapidly under a high-GSH tumor environment. The HA-Fe-C14/DOX micelles were able to accumulate efficiently in tumor and showed significant anticancer effect both in vitro and in vivo. These results suggest that HA-Fe-C14/DOX micelles are a useful drug delivery system that enhances synergic antitumor treatment effects.


Subject(s)
Doxorubicin/chemistry , Doxorubicin/therapeutic use , Drug Delivery Systems , Ferrous Compounds/chemistry , Glutathione/chemistry , Hyaluronic Acid/chemistry , Metallocenes/chemistry , Micelles , Neoplasms/therapy , Alkanes/chemistry , Animals , Cell Survival/drug effects , Combined Modality Therapy , Drug Liberation , Ferrous Compounds/chemical synthesis , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasms/pathology , PC-3 Cells , Solubility , Treatment Outcome , Tumor Burden
SELECTION OF CITATIONS
SEARCH DETAIL
...